Novo Holdings A/S’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.3M | Buy |
660,000
+170,000
| +35% | +$9.34M | 2.56% | 13 |
|
|
2025
Q1 | $34.6M | Hold |
490,000
| – | – | 2.63% | 11 |
|
|
2024
Q4 | $32.2M | Hold |
490,000
| – | – | 1.95% | 16 |
|
|
2024
Q3 | $34.4M | Hold |
490,000
| – | – | 1.71% | 17 |
|
|
2024
Q2 | $40.3M | Buy |
490,000
+40,000
| +9% | +$3.29M | 2.17% | 13 |
|
|
2024
Q1 | $39.3M | Hold |
450,000
| – | – | 2.71% | 11 |
|
|
2023
Q4 | $43.4M | Buy |
450,000
+50,000
| +13% | +$4.82M | 2.68% | 12 |
|
|
2023
Q3 | $35.4M | Hold |
400,000
| – | – | 2.62% | 14 |
|
|
2023
Q2 | $34.7M | Buy |
400,000
+32,620
| +9% | +$2.83M | 2.68% | 13 |
|
|
2023
Q1 | $35.7M | Buy |
367,380
+49,680
| +16% | +$4.83M | 2.36% | 16 |
|
|
2022
Q4 | $32.9M | Buy |
317,700
+200
| +0.1% | +$20.7K | 2.05% | 17 |
|
|
2022
Q3 | $26.9M | Hold |
317,500
| – | – | 1.28% | 18 |
|
|
2022
Q2 | $26.3M | Buy |
+317,500
| New | +$26.3M | 1.3% | 19 |
|